LinkCore Pharma Corporation is a pharmaceutical licensing and development company that focuses on identifying early stage, innovative and market driven pharmaceutical technologies in various therapeutic areas that aim to enhance current pharmaceutical treatments and satisfy unmet medical needs. Our lead product is currently being developed for the treatment of several types of cancers including melanoma, breast, colon, and non-small cell lung carcinomas. The Company is unique in that it sources and secures new inventions that are available for exclusive acquisition and development from a vast worldwide technology pipeline located within universities and other research centres, thereby creating a diverse product portfolio for LinkCore. The Company intends to leverage its products through strategic licensing and partnership arrangements at an early stage of development to accelerate commercialisation. Hence our signature: Identify, Acquire, Optimize, License |
605-1749 Robson Street Phone: 604 488 8880  |